We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+18.78%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.66B
AUM Growth
+$275M
Cap. Flow
+$68.7M
Cap. Flow %
4.14%
Top 10 Hldgs %
23.67%
Holding
233
New
36
Increased
109
Reduced
61
Closed
26

Top Buys

Rank Stock Value
1
WW
WW International
WW
+$23.8M
2
GLOB icon
Globant
GLOB
+$21.8M
3
PAYC icon
Paycom
PAYC
+$17.3M
4
GTLS
Chart Industries
GTLS
+$13.6M
5
SODA
SodaStream International Ltd
SODA
+$12.4M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$10.8M
2
ULTI
Ultimate Software Group Inc
ULTI
+$9.84M
3
MB
MINDBODY, Inc. Class A Common Stock
MB
+$9.71M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$9.52M
5
AXON
Axon Enterprise
AXON
+$9.38M

Sector Composition

Rank Sector Weight
1 Technology 32.93%
2 Healthcare 19.82%
3 Industrials 15.24%
4 Consumer Discretionary 9.82%
5 Consumer Staples 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VST icon
176
Vistra
VST
$47.4B
$1.34M 0.08%
56,786
+9,472
+20% +$218K
EPAM icon
177
EPAM Systems
EPAM
$5.03B
$1.34M 0.08%
10,800
-200
-2% -$24.1K
JYNT icon
178
The Joint Corp
JYNT
$119M
$1.32M 0.08%
+161,929
New +$1.21M
TYL icon
179
Tyler Technologies
TYL
$12.8B
$1.22M 0.07%
5,507
-1,025
-16% -$231K
AKAO
180
DELISTED
Achaogen Inc
AKAO
$1.22M 0.07%
+140,861
New +$1.72M
SOHO
181
DELISTED
Sotherly Hotels
SOHO
$1.18M 0.07%
169,137
+24,848
+17% +$169K
AKAM icon
182
Akamai
AKAM
$15.9B
$1.06M 0.06%
+14,505
New +$1.09M
JNCE
183
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.01M 0.06%
131,592
+11,007
+9% +$159K
FLGT icon
184
Fulgent Genetics
FLGT
$527M
$941K 0.06%
227,233
+34,229
+18% +$136K
STLD icon
185
Steel Dynamics
STLD
$37.6B
$859K 0.05%
18,691
+12,850
+220% +$608K
LYV icon
186
Live Nation Entertainment
LYV
$42.1B
$745K 0.04%
+15,329
New +$656K
LRMR icon
187
Larimar Therapeutics
LRMR
$432M
$712K 0.04%
5,804
+792
+16% +$67.3K
LOVE
188
LoveSac
LOVE
$261M
$667K 0.04%
+32,155
New +$708K
RAMP icon
189
LiveRamp
RAMP
$2.3B
$645K 0.04%
+21,521
New +$589K
FENC icon
190
Fennec Pharmaceuticals
FENC
$402M
$595K 0.04%
57,002
+9,626
+20% +$114K
AVEO
191
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$406K 0.02%
17,951
+2,513
+16% +$59.6K
FBRX icon
192
Forte Biosciences
FBRX
$1.57B
$396K 0.02%
113
+15
+15% +$54.9K
XFOR icon
193
X4 Pharmaceuticals
XFOR
$460M
$365K 0.02%
+559
New +$1.83M
PODD icon
194
Insulet
PODD
$9.79B
$320K 0.02%
+3,734
New +$335K
MTCH icon
195
Match Group
MTCH
$8.55B
$316K 0.02%
8,166
-5,505
-40% -$231K
NEOG icon
196
Neogen
NEOG
$2.5B
$283K 0.02%
+7,066
New +$261K
STIM icon
197
Neuronetics
STIM
$166M
$266K 0.02%
+10,000
New +$272K
FCFS icon
198
FirstCash
FCFS
$8.78B
$252K 0.02%
+2,810
New +$249K
VYNT
199
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$246K 0.01%
1,843
+273
+17% +$41.3K
HAE icon
200
Haemonetics
HAE
$4B
$229K 0.01%
+2,550
New +$215K
6 7
8
9 10

Similar funds

HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Granahan Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Granahan Investment Management held 233 positions worth $1.66B, up 20% from $1.38B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Granahan Investment Management deployed $68.7M of net new capital in Q2 2018, opening 36 new positions and adding to 109 existing holdings. Its largest new stake was Globant: 437,078 shares worth $24.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Teladoc Health, an estimated $10.8M trimmed.

  • Granahan Investment Management's largest Q2 2018 buy was Globant: 437,078 shares worth $24.8M.
  • Granahan Investment Management added most to WW International in Q2 2018, an estimated $23.8M increase.
  • Granahan Investment Management's biggest Q2 2018 reduction was Teladoc Health, cutting an estimated $10.8M.
  • Granahan Investment Management fully exited MINDBODY, Inc. Class A Common Stock in Q2 2018, selling an estimated $9.71M.
  • Granahan Investment Management's ten largest holdings make up 24% of its $1.66B portfolio in Q2 2018.
  • Granahan Investment Management opened 36 new positions and closed 26 in Q2 2018.
  • Granahan Investment Management's portfolio value rose 20% quarter-over-quarter to $1.66B.

Based on Granahan Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.